sglt2 inhibitors vs glp-1 Common systemic effects of either or GLP-1R agonists How do SGLT-2 inhibitors, GLP-1

"With the socioeconomic constraints, the cost variables that are at play, we have huge concerns that a large percentage of our patient base that is reliant on compounded formularies that you can get for $100 to $200 a month and now they are faced with having to pay $1,000, we're concerned about where those patients are going to go," he said

While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight

adjusted HR, 1.79

10.3389/fphar.2018.01168 39 JiangY.YangJ.XiaL.WeiT.CuiX.WangD.et al (2024)